This effect was mediated through the induction of stanniocalcin-1 (STC1), phosphorylation of protein kinase B and mammalian target of rapamycin (mTOR), and activation of VEGFR2/VEGFA signaling in ECs, thereby improving neurovascular function after stroke (Bi et al., 2022). The gene discussed is MTOR; the disease is stroke disorder.